Loading...
GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets
Pancreatic cancer has one of the highest mortality rates (5‐year survival ~9%) among cancers. Pancreatic adenocarcinoma (PAAD) is the most common (>80%) and the most lethal type of pancreatic cancer. A need exists for new approaches to treat pancreatic adenocarcinoma. GPCRs, the largest family of...
Saved in:
| Published in: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7205828/ https://ncbi.nlm.nih.gov/pubmed/32060895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.15028 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|